Search Results

Press Releases

Biofidelity and CellCarta partner to deploy Aspyre® Lung in global clinical trials

January 9, 2025

·

3 min read

Bio NC

Biofidelity to present ASPYRE®-Lung data at AACR 2024

Biofidelity announced that new data from its breakthrough product ASPYRE-Lung will be presented in three scientific posters, including a Late Breaking Abstract (LBA), at the upcoming American Association for Cancer Research (AACR) 2024 Annual Meeting, April 5-10, in San Diego, CA.

April 5, 2024

·

2 min read

Press Releases

Biofidelity launches Aspyre® Lung Reagents, now enabling integrated tissue and liquid biopsy analysis

November 15, 2024

·

2 min read

Press Releases

Biofidelity announces three senior leadership team appointments

September 4, 2024

·

2 min read

Press Releases

Biofidelity launches Aspyre® Clinical Test for Lung, now providing next day results from tissue or blood

November 21, 2024

·

3 min read

Bio NC

Biofidelity launches ASPYRE®-Lung reagents, enabling laboratories worldwide to perform rapid precision genomic analysis

Biofidelity today announced the commercial launch of its ASPYRE ® -Lung RUO reagent product.

December 6, 2023

·

2 min read

Business

Fidelis Sustainability Distribution and Biofidelity Collaborate to Bring Rapid Precision Genomic Testing to Veterans Administration (VA) Customers

Biofidelity and Fidelis Sustainability Distribution (Fidelis) today announced that they have entered into an agreement to make ASPYRE®-Lung available to VA Medical Centers and active military institutions across the US.

January 24, 2024

·

2 min read

Bio NC

Biofidelity announces the commercial launch of ASPYRE-Lung in the US

Biofidelity, a revolutionary genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world, today announced the commercial launch of ASPYRE®-Lung in the US.

September 5, 2023

·

3 min read

Business

Matt Franklin, MBA, appointed as Biofidelity Non-Executive Director

Biofidelity, a revolutionary genomic technology company, has expanded its Board of Directors to include Matt Franklin, MBA, who will join as a Non-Executive Director effective immediately.

November 17, 2022

·

2 min read

Policy

Biofidelity granted key patents in US, Europe, and China

Biofidelity, a revolutionary genomic technology company dedicated to unleashing the potential of genomics to transform human health and the world we live in, announced the issuance of several new patents in the US, Europe, and China.

September 8, 2022

·

4 min read